title: Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.
authors.forename: Nada
authors.initials: N
authors.lastname: Alachkar
authors.forename: Serena M
authors.initials: SM
authors.lastname: Bagnasco
authors.forename: Robert A
authors.initials: RA
authors.lastname: Montgomery
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome; D005260:Female; D006084:Graft Rejection; D006463:Hemolytic-Uremic Syndrome / Q000188:drug therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D010951:Plasma Exchange; D012008:Recurrence
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C481642:eculizumab